Stefan Leis

Stefan Leis

Auto-generated profile, based on publicly available information

Stefan Leis

Paracelsus Medical University of Salzburg

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
BWBetty Wutzl
Betty Wutzl
SGStefan Martin Golaszewski
Stefan Martin Golaszewski
KLKenji Leibnitz
Kenji Leibnitz
PLPatrick B. Langthaler
Patrick B. Langthaler
AKAlexander B. Kunz
Alexander B. Kunz
ETEugen Trinka
Eugen Trinka
In this narrative review, we focus on the role of quantitative EEG technology in the diagnosis and prognosis of patients with unresponsive wakefulness syndrome and minimally conscious state. This paper is divided into two main parts, i.e., diagnosis and prognosis, each consisting of three subsections, namely, (i) resting-state EEG, including spectral power, functional connectivity, dynamic functional connectivity, graph theory, microstates and nonlinear measurements, (ii) sleep patterns, including rapid eye movement (REM) sleep, slow-wave sleep and sleep spindles and (iii) evoked potentials, including the P300, mismatch negativity, the N100, the N400 late positive component and others. Finally, we summarize our findings and conclude that QEEG is a useful tool when it comes to defining the diagnosis and prognosis of DOC patients.

1 July 2021 in Drug Discovery Today
Verified
Journal Article
Open access
SAStephanie Aschauer-Wallner
Stephanie Aschauer-Wallner
SLStefan Leis
Stefan Leis
UBUlrich Bogdahn
Ulrich Bogdahn
SJSiw Johannesen
Siw Johannesen
SCSebastien Couillard-Despres
Sebastien Couillard-Despres
LALudwig Aigner
Ludwig Aigner
Granulocyte colony-stimulating factor (G-CSF) is a cytokine used in pharmaceutical preparations for the treatment of chemotherapy-induced neutropenia. Evidence from experimental studies indicates that G-CSF exerts relevant activities in the central nervous system (CNS) in particular after lesions. In acute, subacute, and chronic CNS lesions, G-CSF appears to have strong anti-inflammatory, antiapoptotic, antioxidative, myelin-protective, and axon-regenerative activities. Additional effects result in the stimulation of angiogenesis and neurogenesis as well as in bone marrow stem cell mobilization to the CNS. There are emerging preclinical and clinical data indicating that G-CSF is a safe and effective drug for the treatment of acute and chronic traumatic spinal cord injury (tSCI), which we summarize in this review.

1 July 2023 in Wiener klinische Wochenschrift
Verified
Journal Article
Open access
PDF file
SRSusanne Rabady
Susanne Rabady
KHKathryn Hoffmann
Kathryn Hoffmann
MAMartin Aigner
Martin Aigner
JAJohann Altenberger
Johann Altenberger
MBMarkus Brose
Markus Brose
RZRalf-Harun Zwick
Ralf-Harun Zwick
Zusammenfassung: Die vorliegende Leitlinie S1 ist die Aktualisierung und Weiterentwicklung der Leitlinie S1 Long COVID: Differenzialdiagnostik und Behandlungsstrategien. Sie fasst den Stand der Kenntnis zu postviralen Zuständen anhand des Beispiels Long/Post COVID zum Zeitpunkt des Redaktionsschlusses zusammen. Aufgrund der starken Dynamik der Wissensentwicklung versteht sie sich als „living guideline“. Der Schwerpunkt liegt auf der praktischen Anwendbarkeit auf der Ebene der hausärztlichen Primärversorgung, die als geeignete Stelle für den Erstzutritt und für die primäre Betreuung und Behandlung verstanden wird. Die Leitlinie gibt Empfehlungen zum Versorgungsgang, zu Differenzialdiagnostik der häufigsten Symptome, die in der Folge einer Infektion wie mit SARS-CoV‑2 auftreten können, zu therapeutischen Optionen, zu Patient:innenführung und -betreuung sowie zur Wiedereingliederung in den Alltag und zur Rehabilitation. Entsprechend des Krankheitsbildes ist die Leitlinie in einem interdisziplinären und interprofessionellen Prozess entstanden und gibt Empfehlungen zu Schnittstellen und Kooperationsmöglichkeiten.

19 November 2018 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
Yvonne HöllerYvonne Höller
Yvonne Höller
ATAljoscha Thomschewski
Aljoscha Thomschewski
AUAndreas Uhl
Andreas Uhl
ABArne C. Bathke
Arne C. Bathke
RNRaffaele Nardone
Raffaele Nardone
PHPeter Höller
Peter Höller
Brain computer interfaces (BCIs) are thought to revolutionize rehabilitation after SCI, e.g., by controlling neuroprostheses, exoskeletons, functional electrical stimulation, or a combination of these components. However, most BCI research was performed in healthy volunteers and it is unknown whether these results can be translated to patients with spinal cord injury because of neuroplasticity. We sought to examine whether high-density EEG (HD-EEG) could improve the performance of motor-imagery classification in patients with SCI. We recorded HD-EEG with 256 channels in 22 healthy controls and 7 patients with 14 recordings (4 patients had more than one recording) in an event related design. Participants were instructed acoustically to either imagine, execute, or observe foot and hand movements, or to rest. We calculated Fast Fourier Transform (FFT) and full frequency directed transfer function (ffDTF) for each condition and classified conditions pairwise with support vector machines when using only 2 channels over the sensorimotor area, full 10-20 montage, high-density montage of the sensorimotor cortex, and full HD-montage. Classification accuracies were comparable between patients and controls, with an advantage for controls for classifications that involved the foot movement condition. Full montages led to better results for both groups (p < 0.001), and classification accuracies were higher for FFT than for ffDTF (p < 0.001), for which the feature vector might be too long. However, full-montage 10–20 montage was comparable to high-density configurations. Motor-imagery driven control of neuroprostheses or BCI systems may perform as well in patients as in healthy volunteers with adequate technical configuration. We suggest the use of a whole-head montage and analysis of a broad frequency range.

1 October 2019 in Peptides
Verified
Journal Article
Closed access
SBSusanne Maria Brunner
Susanne Maria Brunner
AKAndreas Koller
Andreas Koller
JSJulia Stockinger
Julia Stockinger
FSFelix Sternberg
Felix Sternberg
SLStefan Leis
Stefan Leis
BKBarbara Kofler
Barbara Kofler

28 April 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
CFCristina Florea
Cristina Florea
CBChristine Bräumann
Christine Bräumann
CMChristine Mussger
Christine Mussger
SLStefan Leis
Stefan Leis
LHLarissa Hauer
Larissa Hauer
SGStefan Martin Golaszewski
Stefan Martin Golaszewski
Dysphagia after stroke impacts quality of life and is a risk factor for respiratory infections. Patients frequently require prophylactic measures including nasogastric tube or percutaneous endoscopic gastrostomy. Until recently, therapy for dysphagia was limited to training with a speech and language specialist. Intraluminal pharyngeal electrical stimulation (PES) is a new technique that stimulates the pharyngeal sensory afferents to the higher swallowing center in cortex. The clinical trials published to date involved stimulation for 10 minutes over three days. We present a case of brainstem infarction with severe dysphagia in a 53-year-old woman with preserved cognitive functions. For airway protection, she had a surgical tracheotomy. The initial swallowing training achieved slight improvements, but stagnated after three months so PES was tried. Under good PES tube tolerance, a prolonged and repeated stimulation protocol was administered, with the main purpose of relieving her of the tracheal tube. Although the swallowing improved, she stayed tube-dependent with minimal attempts with puréed food during therapy, and could not be decannulated. Further studies are required to assess the value of this promising approach for the treatment of dysphagia.